2026-01-14 - Analysis Report
**Company Overview**
UnitedHealth Group Inc, a diversified health care company.

**Return Comparison with S&P 500 (VOO)**
- Cumulative return of review stock: -20.83%
- Cumulative return of comparison stock (S&P 500, VOO): 93.94%
- Degree of divergence (difference in cumulative return on the last day of the data): N/A

**CAGR/Beta/MDD Analysis**
| Year  | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018  | 22.0% | 18.6% | 19.0% | 0.9 | 225.7B |
| 2017-2019  | 27.0% | 18.6% | 10.0% | 0.9 | 266.3B |
| 2018-2020  | -41.0% | 32.5% | -62.0% | 1.1 | 317.7B |
| 2019-2021  | 16.0% | 32.5% | -27.0% | 1.1 | 454.9B |
| 2020-2022  | 0.0% | 31.5% | 2.0% | 0.9 | 480.3B |
| 2021-2023  | 23.0% | 13.4% | 23.0% | 0.5 | 476.9B |
| 2022-2024  | -24.0% | 23.1% | -44.0% | 0.4 | 458.2B |
| 2023-2025  | -55.0% | 58.5% | -118.0% | 0.3 | 299.0B |

**Stock Price Analysis**
- Close: $333.93
- 5-day SMA: $341.39
- 20-day SMA: $334.87
- 60-day SMA: $335.16

**RSI/PPO/Delta Analysis**
- RSI: 57.34
- PPO: 0.16
- Market Risk Indicator (MRI): 0.70 (Medium Investment Recommended)
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: -0.90 (-)
- 7-day Rank change: -3 (-)
- 7-day Dynamic Expected Return change: -38.60 (-)
- Expected Return (%): -274.70%

**News & Significant Events**
- [2026-01-12] UnitedHealth Faces Renewed Scrutiny into Its Nursing Home Practices. What Does That Mean for UNH Stock? - Yahoo Finance
- [2026-01-13] UnitedHealth: Inflection Confirmation Imminent (NYSE:UNH) - Seeking Alpha
- [2026-01-11] Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings? - TipRanks
- [2026-01-12] What's Going On With UnitedHealth Group Stock Monday? - UnitedHealth Group (NYSE:UNH) - Benzinga
- [2026-01-13] Are UnitedHealth Group Incorporated's (NYSE:UNH) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
- [2026-01-13] UnitedHealth Could Re-Take Its All-Time High In 2026 (NYSE:UNH) - Seeking Alpha

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 393.85 / 444.00 / 280.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9 | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

**Financial Information**

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

**Comprehensive Analysis**

- The review stock (UNH) has a significant divergence in cumulative return compared to the S&P 500 (VOO) with a degree of -20.83% in the past period.
- The review stock's Alpha and Beta values in the provided data period show fluctuations.
- The review stock's current Market Risk Indicator (MRI) is 0.70, indicating a Medium Investment Recommended.
- The recent news and significant events for the review stock include renewed scrutiny into its nursing home practices and potential for an inflection confirmation imminent.
- The analyst consensus has a key of Buy with a mean rating of 1.93 and recommends an average target price of $393.85.
- The review stock has shown fluctuations in its recent earnings with an EPS of 2.59 and Revenue of 113.16 B$.
- The review stock's financial information shows variations in Revenue and Profit Margin among the different quarters.
- Given the expected return (-274.70%), the review stock may not be advisable to invest in, considering the current market situation.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.